• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔凝胶作为由市售片剂配制的液体儿科混悬剂的替代品。

Oral Gels as an Alternative to Liquid Pediatric Suspensions Compounded from Commercial Tablets.

作者信息

Trofimiuk Monika, Sznitowska Małgorzata, Winnicka Katarzyna

机构信息

Department of Clinical Pharmacy, Medical University of Bialystok, 15-222 Bialystok, Poland.

Department of Pharmaceutical Technology, Medical University of Bialystok, 15-222 Bialystok, Poland.

出版信息

Pharmaceutics. 2024 Sep 20;16(9):1229. doi: 10.3390/pharmaceutics16091229.

DOI:10.3390/pharmaceutics16091229
PMID:39339265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11434729/
Abstract

The aim of the study was to propose pharmacy-compounded oral gels as a new and alternative dosage form that is attractive to children as having a better masking taste than syrups and reducing the risk of spilling. The application and physical properties of the gels prepared with cellulose derivatives (hydroxyethylcellulose and carmellose sodium) or carbomers were evaluated. The results of the study showed the most suitable consistency, viscosity, and organoleptic properties for gels prepared with carbomer and cellulose derivatives at concentrations of 0.75% and 2.0%, respectively. The microbial stability of the gels was guaranteed by the use of methylparaben and potassium sorbate. VAL (valsartan) and CC (candesartan cilexetil) tablets, often used off-label in children, were pulverized and suspended in the hydrogel bases, resulting in final drug concentrations of 4 mg/g and 1 mg/g, respectively. There was no significant change in viscosity and consistency parameters when the pulverized tablets were added, and only small changes in viscosity and consistency were observed during 35 days of storage, especially in the gels with sodium carmellose and candesartan. On the basis of the drug assay, an expiry date of 25 °C was recommended: 35 days for valsartan and 14 days for candesartan preparations.

摘要

该研究的目的是提出一种药房配制的口服凝胶剂,作为一种新的替代剂型,这种剂型对儿童有吸引力,因为它比糖浆剂具有更好的掩味效果,且降低了溢出风险。对用纤维素衍生物(羟乙基纤维素和羧甲基纤维素钠)或卡波姆制备的凝胶剂的应用和物理性质进行了评估。研究结果表明,对于分别用浓度为0.75%的卡波姆和2.0%的纤维素衍生物制备的凝胶剂,其具有最合适的稠度、粘度和感官性质。通过使用对羟基苯甲酸甲酯和山梨酸钾保证了凝胶剂的微生物稳定性。将常用于儿童超说明书用药的缬沙坦(VAL)和坎地沙坦酯(CC)片剂粉碎并悬浮于水凝胶基质中,最终药物浓度分别为4mg/g和1mg/g。加入粉碎的片剂后,粘度和稠度参数没有显著变化,并且在储存35天期间仅观察到粘度和稠度有微小变化,尤其是在含有羧甲基纤维素钠和坎地沙坦的凝胶剂中。基于药物分析,建议在25℃下的有效期为:缬沙坦制剂35天,坎地沙坦制剂14天。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/77c5cdb7e715/pharmaceutics-16-01229-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/64a75b1255f3/pharmaceutics-16-01229-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/53a64857d60a/pharmaceutics-16-01229-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/94a6b59479b0/pharmaceutics-16-01229-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/c8a1975f8db1/pharmaceutics-16-01229-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/6a1acc33bba8/pharmaceutics-16-01229-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/77c5cdb7e715/pharmaceutics-16-01229-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/64a75b1255f3/pharmaceutics-16-01229-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/53a64857d60a/pharmaceutics-16-01229-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/94a6b59479b0/pharmaceutics-16-01229-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/c8a1975f8db1/pharmaceutics-16-01229-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/6a1acc33bba8/pharmaceutics-16-01229-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f961/11434729/77c5cdb7e715/pharmaceutics-16-01229-g006.jpg

相似文献

1
Oral Gels as an Alternative to Liquid Pediatric Suspensions Compounded from Commercial Tablets.口腔凝胶作为由市售片剂配制的液体儿科混悬剂的替代品。
Pharmaceutics. 2024 Sep 20;16(9):1229. doi: 10.3390/pharmaceutics16091229.
2
Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.复方分散介质在坎地沙坦酯和缬沙坦临时配制儿科糖浆中的应用。
Acta Pharm. 2014 Dec;64(4):463-74. doi: 10.2478/acph-2014-0037.
3
Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients.口腔凝胶作为将迷你片剂和丸剂给予儿科患者的给药介质的应用特性。
Int J Pharm. 2014 Jan 2;460(1-2):228-33. doi: 10.1016/j.ijpharm.2013.10.052. Epub 2013 Nov 9.
4
The stability of quetiapine oral suspension compounded from commercially available tablets.市售片剂制备的喹硫平口服混悬液的稳定性。
PLoS One. 2021 Aug 10;16(8):e0255963. doi: 10.1371/journal.pone.0255963. eCollection 2021.
5
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.复方苯磺酸氨氯地平悬浮液在PCCA基质(SuspendIt)中的物理化学稳定性
Int J Pharm Compd. 2019 Nov-Dec;23(6):519-527.
6
Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt®.PCCA 基质混悬剂中盐酸可乐定口服液体制剂的理化和微生物稳定性。
Int J Pharm Compd. 2024 Jul-Aug;28(4):334-343.
7
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.PCCA SuspendIt 中配制的甲硝唑混悬液的理化和微生物稳定性。
Int J Pharm Compd. 2021 Mar-Apr;25(2):169-175.
8
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.复方别嘌醇混悬液在PCCA基质(SuspendIt)中的物理化学稳定性
Int J Pharm Compd. 2020 Sep-Oct;24(5):413-419.
9
Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt®.PCCA 基混悬剂(SuspendIt®)中配制的氯化氨甲酰胆碱口服混悬液的物理化学和微生物稳定性。
Int J Pharm Compd. 2024 Jul-Aug;28(4):321-328.
10
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.PCCA 基质混悬剂中临时配制的氢化可的松口服混悬液的物理化学和微生物稳定性
Int J Pharm Compd. 2021 Sep-Oct;25(5):431-439.

本文引用的文献

1
Off-Label Prescribing in Pediatric Population-Literature Review for 2012-2022.儿科人群的超说明书用药——2012年至2022年文献综述
Pharmaceutics. 2023 Nov 21;15(12):2652. doi: 10.3390/pharmaceutics15122652.
2
Rheology of Gels and Yielding Liquids.凝胶与屈服液体的流变学
Gels. 2023 Sep 3;9(9):715. doi: 10.3390/gels9090715.
3
Narrative update of clinical trials with antihypertensive drugs in children and adolescents.儿童和青少年使用抗高血压药物的临床试验的叙述性更新。
Front Cardiovasc Med. 2022 Nov 21;9:1042190. doi: 10.3389/fcvm.2022.1042190. eCollection 2022.
4
Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.开发儿科剂型的配方挑战与策略
Children (Basel). 2022 Apr 1;9(4):488. doi: 10.3390/children9040488.
5
The Influence of Tea Tree Oil on Antifungal Activity and Pharmaceutical Characteristics of Pluronic F-127 Gel Formulations with Ketoconazole.茶树油对酮康唑泊洛沙姆 F-127 凝胶制剂抗真菌活性和药物特性的影响。
Int J Mol Sci. 2021 Oct 20;22(21):11326. doi: 10.3390/ijms222111326.
6
Preparation and evaluation of benzalkonium chloride hand sanitizer as a potential alternative for alcohol-based hand gels.苯扎氯铵洗手液作为酒精基洗手液潜在替代品的制备与评价
Saudi Pharm J. 2021 Aug;29(8):807-814. doi: 10.1016/j.jsps.2021.06.002. Epub 2021 Jun 12.
7
Safety evaluation of crosslinked polyacrylic acid polymers (carbomer) as a new food additive.交联聚丙烯酸聚合物(卡波姆)作为新型食品添加剂的安全性评估
EFSA J. 2021 Aug 11;19(8):e06693. doi: 10.2903/j.efsa.2021.6693. eCollection 2021 Aug.
8
Benefit-Risk Assessment of Off-Label Drug Use in Children: The Bravo Framework.儿童超适应证用药的获益-风险评估: Bravo 框架。
Clin Pharmacol Ther. 2021 Oct;110(4):952-965. doi: 10.1002/cpt.2336. Epub 2021 Jul 29.
9
Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).儿童对口服剂型的偏好以及他们通过欧洲儿科转化研究基础设施(EPTRI)参与剂型研究的情况。
Pharmaceutics. 2021 May 15;13(5):730. doi: 10.3390/pharmaceutics13050730.
10
Oral dextrose gel to prevent hypoglycaemia in at-risk neonates.口服葡萄糖凝胶预防高危新生儿低血糖
Cochrane Database Syst Rev. 2021 May 17;5(5):CD012152. doi: 10.1002/14651858.CD012152.pub3.